Dr. Nerea Lopetegui-Lia on the Implications of the DESTINY Breast-06 Data for Clinical Practice

At the Advancements in Oncology event, hosted by The Oncology Brothers, Margaret Gatti-Mays, MD, MPH provided excellent insights into breast cancer treatment innovations. Here, Nera Lopetegui-Lia, MD, of Taussig Cancer Institute, gives her reaction to Dr. Gatti-Mays' panel discussion, particularly as it pertains to how data from the DESTINY Breast-06 study impacts clinical oncology practice.